[1] 李恒,胡志全.前列腺癌冷冻消融治疗新进展[J].现代泌尿生殖肿瘤杂志,2011,3(6):362-365.
[2] MARIUCCI S,ROVATI B,MANZONI M,et al.Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors[J].Clin Exp Med,2011,11(4):199-210.
[3] JEMAL A,SIEGEL R,XU J,et al.Cancer statistics,2010[J].CA Cancer J Clin,2010,60(5):277-300.
[4] 赵平,陈万青.中国肿瘤登记年报[M].北京:中国协和医科大学,2004:365.
[5] TURPEN R,ROSSER C J.Focal therapy for prostate cancer:revolution or evolution？[J].BMC Urol,2009,9:2.
[6] PISTERS L L.Cryotherapy for prostate cancer:ready for prime time？[J].Curr Opon Urol,2010,20(3):218-222.
[7] BABAIAN R J,DONNELLY B,BAHN D,et al.Best practice statement on cryosurgery for the treatment of localized prostate cancer[J].J Urol,2008,180(5):1993-2004.
[8] SABEL M S.Cryo-immunology:a review of the literature and proposed mechanisms for stimulatory versus suppressive immune response[J].Cryobiology,2009,58(1):1-11.
[9] LONG J P,BAHN D,LEE F,et al.Five-year retrospective,multiinstitutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate[J].Urology,2001,57(3):518-523.
[10] DONELLY B J,SALIKEN J C,ERNST D S,et al.Prospective trial of cryosurgical ablation of the prostate:five year results[J].Urology,2002,60(4):645-649.
[11] HAN K R,COHEN J K,MILLER R J,et al.Treatment of organ confined prostate cancer with third generation cryosurgery:preliminary multicentre experience[J].J Urol,2003,170(4 pt 1):1126-1130.
[12] BAHN D K,LEE F,BALDALAMENT R,et al.Targeted cryoablation of the prostate:7-year outcomes in the primary treatment of prostate cancer[J].Urology,2002,60(2 Suppl):3-11.
[13] JONES J S,REWCASTLE J C,DONNELLY B J,et al.Whole gland primary prostate cryoablation:initial results from the cryo on line data registry[J].J Urol,2008,180(2):554-558.
[14] LEVY D A,PISTERS L L,JONES J S.Primary cryoablation nadir prostate specific antigen and biochemical failure[J].J Urol,2009,182(3):931-937.
[15] NG C K,MOUSSA M,DOWNEY D B,et al.Salvage cryoablation of the prostate:followup and analysis predictive factors for outcome[J].J Urol,2007,178(4 Pt 1):1253-1257.
[16] KOPPIE T M,SHINOHARA K,GROSSFELD G D,et al.The efficacy of cryosurgical ablation of prostate cancer:the University of California,San Francisco experience[J].J Urol,1999,162(2):427-432.
[17] PISTERS L L,von ESCHENBACH A C,SCOTT S M,et al.The efficacy and complications of salvage cryotherapy of the prostate[J].J Urol,1997,157(3):921-925.
[18] CHIN J L,PAUTLER S E,MOURAVIEV V,et al.Results of salvage cryoablation of the prostate after radiation:identifying predictors of treatment failure and complications[J].J Urol,2001,165(6 Pt 1):1937-1941,discussion 1941-1942.
[19] 丁辉,王志平.泌尿系肿瘤的冷冻治疗进展[J].现代泌尿生殖肿瘤杂志,2012,4(4):237-241.
[20] RAVINDRANATH M H,WOOD T F,SOH D,et al.Cryosurgical ablation of liver tumors in colon canceg patients increases the serum total ganglioside level and then selectively augments antiganglioside IgM[J].Cryobiology,2002,45(1):10-21.
[21] OSADA S,IMAI H,TOMITA H,et al.Serum cytokine levels in response to hepatic cryoablation[J].J Surg Oncol,2007,95(6):491-498.
[22] MARIUCCI S,ROVATI B,MANZONI M,et al.Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors[J].Clin Exp Med,2011,11(4):199-200.
[23] RUBINSKY B.Cryosurgery[J].Annu Rev Biomed Eng,2000,2:157-187.
[24] 李鸣,孙光,贺大林,等.前列腺癌诊断治疗指南[M]//那彦群.中国泌尿外科疾病诊断诊疗指南.北京:人民卫生出版社,2011:39-79. |
